Jmcgh and Other sites: Non-Urine Sites Only

 Numbers are percent susceptible

 

Gram Negative

 Organisms

No. of

isolates

amk

am/s

cz

fep

caz

cx

etp

gm

le

mer

tmp/

smx

Acinetobacter

baumannii

104

 

-

87

-

63

47

-

-

87

61

86

56

Citrobacter

freundii

22

100

-

0

100

73

77

100

82

82

100

68

Citrobacter

koseri

27

100

-

93

100

96

100

100

100

96

100

96

Enterobacter

aerogenes

35

100

-

0

100

94

97

100

100

97

100

100

Enterobacter

cloacae

123

100

-

0

97

81

84

94

93

86

100

85

Escherichia

coli

603

100

51

82

90

89

89

99

86

54

99

60

 

Klebsiella

oxytoca

55

100

85

82

98

95

95

100

98

96

100

95

Klebsiella

pneumoniae

208

100

84

92

93

93

93

97

95

95

98

91

Morganella

morganii

63

100

0

0

97

65

97

100

81

59

100

59

Proteus

 mirabilis

430

100

71

81

85

85

85

88

81

46

88

58

Providencia stuartii

38

100

0

0

100

97

100

-

79

32

100

63

Pseudomonas

aeruginosa

550

97

-

-

85

84

-

-

86

64

81

-

Serratia

marcescens

92

100

-

0

100

99

98

98

99

98

99

98

Stenotrophomonas maltophilia

88

-

-

-

-

-

-

-

-

88

-

97

 

 

Comments:

·          74% of Haemophilus infuenzae isolates were beta lactamase negative (78 isolates tested). Beta Lactamase negative indicates probable susceptibility to penicillin, ampicillin and 1st generation cephalosporins. Beta lactamase positive indicates probable resistance to ampicillin, amoxicillin and first generation cephalosporins. Recommended therapy is combination therapy or a third generation cephalosporin.

·          96% of Moraxella (Branhamella) catarrhalis were beta lactamase positive (27 isolates tested). Beta lactamase positive indicates resistance to penicillin, ampicillin and first generation cephalosporins. Several beta-lactams are effective including beta lactam/Beta Lactamase inhibitory combinations, 3rd generation cephalosporins, macrolides, quinolones and trimethoprim/sulfamethoxazole.

·          47 isolates of Salmonella species and 2 Shigella species were recovered. Susceptibility testing is not routinely performed on intestinal sites. Extraintestinal sites are tested against ampicillin, trimethoprim/sulfa and a third generation cephalosporin. Intestinal source isolates will be tested per telephone request.

·          3 Campylobacter species were isolated in 2012.

·          6 Giardia lamblia positive rapid antigens were confirmed in 2012.

·          0 Cryptosporidium positive rapid antigens were confirmed in 2012.

·          Beta hemolytic Streptococcus species have not demonstrated resistance to penicillin or ampicillin therefore susceptibility testing is not routinely performed. Of the Streptococcus agalactiae performed on isolates recovered from pregnant penicillin allergic women 100% were Penicillin sensitive, 39% were Clindamycin sensitive and 27% were Erythromycin sensitive. Erythromycin resistant strains cannot be reliably interpreted as Clindamycin sensitive without the addition of the “D Test” to test for inducible resistance.

Beginning in 2007 susceptibility testing will be performed by manual Kirby-Bauer Disk Diffusion Method due to a limitation with the Erythromycin/Streptococcus agalactiae anitibioitc/organism combination using the bioMerieux automated identification susceptibility system.

·          Vancomycin resistant Enterococcus species are speciated and the Vancomycin MIC confirmed by alternative methods.